A detailed history of Principal Securities, Inc. transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Principal Securities, Inc. holds 481 shares of PACB stock, worth $774. This represents 0.0% of its overall portfolio holdings.

Number of Shares
481
Previous 719 33.1%
Holding current value
$774
Previous $892,000 30.94%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

SELL
$1.17 - $1.69 $278 - $402
-238 Reduced 33.1%
481 $616,000
Q3 2024

Oct 28, 2024

BUY
$1.2 - $2.17 $420 - $759
350 Added 94.85%
719 $1.22 Million
Q2 2024

Jul 31, 2024

SELL
$1.36 - $3.65 $204 - $547
-150 Reduced 28.9%
369 $506,000
Q1 2024

May 10, 2024

BUY
$3.52 - $9.59 $158 - $431
45 Added 9.49%
519 $1.95 Million
Q4 2023

Feb 07, 2024

BUY
$5.97 - $10.36 $2,829 - $4,910
474 New
474 $4.65 Million

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $362M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Principal Securities, Inc. Portfolio

Follow Principal Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Principal Securities, Inc. with notifications on news.